Ticker Details
Crinetics Pharmaceuticals, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.71 | 2.68%
Avg Daily Range (30 D):	$0.97 | 2.46%
Avg Daily Range (90 D):	$0.96 | 2.26%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	.93M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	2,985
Avg Institutional Trade:	$2.86M
Avg Institutional Trade (30 D):	$2.76M
Avg Institutional Trade (90 D):	$3.17M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.57M
Avg Closing Trade (30 D):	$6.05M
Avg Closing Trade (90 D):	$6.29M
Avg Closing Volume:	126.32K

News

Apr 15, 2026 @ 6:00 PM Neutrolis Appoints Caren Deardorf as Chief Busines... Source: Not Specified

Jan 26, 2026 @ 10:00 PM Crinetics Pharmaceuticals to Report Fourth Quarter... Source: Na

Jan 4, 2026 @ 9:00 PM Crinetics Pharmaceuticals to Provide PALSONIFY Bus... Source: Na

Dec 3, 2025 @ 1:00 PM Crinetics Announces First Patient Dosed in Phase 1... Source: Crinetics Pharmaceuticals

Nov 7, 2025 @ 9:16 PM Why Crinetics Pharmaceuticals Stock Was Sliding on... Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-5.13	$-1.23	$-1.29
Diluted EPS	$-5.13	$-1.23	$-1.29
Revenue	$18.07M	$10.73M	$6.16M
Gross Profit		$10.53M
Net Income / Loss	$-496.39M	$-127.85M	$-122.82M
Operating Income / Loss	$-545.74M	$-140.38M	$-133.67M
Cost of Revenue	$1.28M	$.2M
Net Cash Flow	$19.39M	$12.81M	$-9.76M
PE Ratio